RecruitingPhase 2NCT05272254

Povidone Iodine Efficacy Study


Sponsor

University of Rochester

Enrollment

202 participants

Start Date

Sep 15, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S-ECC). At baseline, following oral rehabilitation in the operating room {10% (PVPI + Fluoride Varnish (FV)} will be compared to the current standard of care (Placebo + FV). Study participants will be followed for approximately 24 months post-baseline. The study interventions post-baseline will be administered at 3, 6, 9, 12, 15, 18, and 21 months.


Eligibility

Min Age: 24 MonthsMax Age: 71 Months

Inclusion Criteria5

  • Provide signed and dated informed consent/permission form
  • Parents/primary caregivers willing to comply with all study procedures and be available for the duration of the study
  • Male or female, of any race, ethnicity, aged 24 to 71 months and their parents/primary caregivers who are 18 years of age or older or emancipated minors
  • In good general health as evidenced by medical history, per PI, and in compliance with current CDC, NYS Department of Health and URMC COVID-19 guidelines. American Society of Anesthesiologists (ASA) categories will be used; children classified as ASA I and ASA II will be eligible for the study.
  • Diagnosed with Severe-Early Childhood Caries (S-ECC) requiring treatment in the operating room (OR). A diagnosis of S-ECC will be based on the definition in accordance with American Academy of Pediatric Dentistry (AAPD)

Exclusion Criteria2

  • Having a known allergy or sensitivity to iodine or seafood, red or yellow food coloring, or to tea, including a hypersensitivity to fluoride varnish, or having thyroid disease, as determined by medical history
  • Receiving or having received treatment with another investigational drug within 30 days of the baseline visit (V1)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG10% povidone iodine + FV

applied to children's teeth

OTHERPlacebo +FV

applied to children's teeth


Locations(1)

University of Rochester

Rochester, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05272254


Related Trials